Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Max Crispin

Showing results (171-180 of 230) with videos related to

Pageof 23
Sort By:
ACS Central Science|May 31, 2021
Native-like SARS-CoV-2 Spike Glycoprotein Expressed by ChAdOx1 nCoV-19/AZD1222 VaccineYasunori Watanabe, Luiza Mendonça, Elizabeth R Allen, et al.
NPJ Vaccines|July 12, 2024
Priming antibody responses to the fusion peptide in rhesus macaquesChristopher A Cottrell, Payal P Pratap, Kimberly M Cirelli, et al.
Biorxiv : the Preprint Server for Biology|January 27, 2021
Native-like SARS-CoV-2 spike glycoprotein expressed by ChAdOx1 nCoV-19/AZD1222 vaccineYasunori Watanabe, Luiza Mendonça, Elizabeth R Allen, et al.
Frontiers in Immunology|July 21, 2022
SARS-CoV-2 Spike- and Nucleoprotein-Specific Antibodies Induced After Vaccination or Infection Promote Classical Complement ActivationRachel E Lamerton, Edith Marcial-Juarez, Sian E Faustini, et al.
Protein Science : a Publication of the Protein Society|March 25, 2015
Eliminating antibody polyreactivity through addition of N-linked glycosylationGwo-Yu Chuang, Baoshan Zhang, Krisha McKee, et al.
Nature Communications|November 26, 2022
Induction of cross-neutralizing antibodies by a permuted hepatitis C virus glycoprotein nanoparticle vaccine candidateKwinten Sliepen, Laura Radić, Joan Capella-Pujol, et al.
Medrxiv : the Preprint Server for Health Sciences|November 25, 2020
Serological responses to SARS-CoV-2 following non-hospitalised infection: clinical and ethnodemographic features associated with the magnitude of the antibody responseAdrian M Shields, Sian E Faustini, Marisol Perez-Toledo, et al.
BMJ Open Respiratory Research|September 25, 2021
Serological responses to SARS-CoV-2 following non-hospitalised infection: clinical and ethnodemographic features associated with the magnitude of the antibody responseAdrian M Shields, Sian E Faustini, Marisol Perez-Toledo, et al.
Biorxiv : the Preprint Server for Biology|June 29, 2026
Translating Innovation to Clinic: End-to-End Bioprocess Development and cGMP Manufacturing of N332-GT5 HIV Vaccine Candidate for First-in-Human Trials HVTN144Sammaiah Pallerla, Shaunak Uplekar, Ferenc Boldog, et al.
Science (New York, N.Y.)|April 28, 2018
Quantitative mass imaging of single biological macromoleculesGavin Young, Nikolas Hundt, Daniel Cole, et al.
Pageof 23

Showing results (171-180 of 230) with videos related to

Sort By:
Pageof 23
ACS Central Science|May 31, 2021
Native-like SARS-CoV-2 Spike Glycoprotein Expressed by ChAdOx1 nCoV-19/AZD1222 VaccineYasunori Watanabe, Luiza Mendonça, Elizabeth R Allen, et al.
NPJ Vaccines|July 12, 2024
Priming antibody responses to the fusion peptide in rhesus macaquesChristopher A Cottrell, Payal P Pratap, Kimberly M Cirelli, et al.
Biorxiv : the Preprint Server for Biology|January 27, 2021
Native-like SARS-CoV-2 spike glycoprotein expressed by ChAdOx1 nCoV-19/AZD1222 vaccineYasunori Watanabe, Luiza Mendonça, Elizabeth R Allen, et al.
Frontiers in Immunology|July 21, 2022
SARS-CoV-2 Spike- and Nucleoprotein-Specific Antibodies Induced After Vaccination or Infection Promote Classical Complement ActivationRachel E Lamerton, Edith Marcial-Juarez, Sian E Faustini, et al.
Protein Science : a Publication of the Protein Society|March 25, 2015
Eliminating antibody polyreactivity through addition of N-linked glycosylationGwo-Yu Chuang, Baoshan Zhang, Krisha McKee, et al.
Nature Communications|November 26, 2022
Induction of cross-neutralizing antibodies by a permuted hepatitis C virus glycoprotein nanoparticle vaccine candidateKwinten Sliepen, Laura Radić, Joan Capella-Pujol, et al.
Medrxiv : the Preprint Server for Health Sciences|November 25, 2020
Serological responses to SARS-CoV-2 following non-hospitalised infection: clinical and ethnodemographic features associated with the magnitude of the antibody responseAdrian M Shields, Sian E Faustini, Marisol Perez-Toledo, et al.
BMJ Open Respiratory Research|September 25, 2021
Serological responses to SARS-CoV-2 following non-hospitalised infection: clinical and ethnodemographic features associated with the magnitude of the antibody responseAdrian M Shields, Sian E Faustini, Marisol Perez-Toledo, et al.
Biorxiv : the Preprint Server for Biology|June 29, 2026
Translating Innovation to Clinic: End-to-End Bioprocess Development and cGMP Manufacturing of N332-GT5 HIV Vaccine Candidate for First-in-Human Trials HVTN144Sammaiah Pallerla, Shaunak Uplekar, Ferenc Boldog, et al.
Science (New York, N.Y.)|April 28, 2018
Quantitative mass imaging of single biological macromoleculesGavin Young, Nikolas Hundt, Daniel Cole, et al.
Pageof 23